Gastroenterologist Dr Leonard Weinstock - 11th March '20 Low Dose Naltrexone (LDN)

In his discussion, Dr. Leonard Weinstock focuses on Systemic Mastocytosis, a condition characterized by an excessive proliferation of mast cells across various organs. Dr. Weinstock highlights Low Dose Naltrexone (LDN) as a primary therapeutic strategy to manage this condition, due to its potential role in modulating the immune response. He also emphasizes complementary treatments including the use of antihistamines to counteract allergic reactions, and supplementary vitamins such as D, B, and C, which may support overall health and immune function. Dietary modifications are also recommended as part of a broader treatment regimen. The talk suggests LDN’s broader applicability in managing autoimmune conditions, chronic pain, and other health challenges.